Absci (ABSI) Interest Expenses (2020 - 2026)
Absci (ABSI) reported Interest Expenses of $8.9 million for Q1 2026, up 54.29% on a YoY basis from $5.8 million in Q1 2025, and up 382.17% sequentially from $1.9 million in Q4 2025.
Absci (ABSI) Interest Expenses (2020 - 2026) Analysis & Trends
Absci (ABSI) has 7 years of Interest Expenses data on file, last reported at $8.9 million in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses rose 54.29% year-over-year to $8.9 million; the trailing twelve-month figure through Mar 2026 stood at $8.9 million (up 54.29% YoY), and the FY2025 full-year result was $106.2 million, up 36.16% from the prior year.
- Interest Expenses improved to $8.9 million in Q1 2026, from $1.9 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $55.4 million in Q1 2024 to a low of -$745000.0 in Q4 2022.
- A 5-year average of $11.2 million and a median of $5.8 million in 2025 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses jumped 9239.78% in 2022 and slumped 93.25% in 2023, its largest moves.
- Tracing ABSI's Interest Expenses over 5 years: stood at -$745000.0 in 2022, then jumped by 122.01% to $164000.0 in 2023, then surged by 1003.66% to $1.8 million in 2024, then rose by 2.54% to $1.9 million in 2025, then jumped by 382.17% to $8.9 million in 2026.
- Business Quant data shows ABSI's Interest Expenses at $8.9 million in Q1 2026, $1.9 million in Q4 2025, and $9.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | 8.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.95 Mn |
| Mar 31, 2026 | 8.95 Mn |
| Dec 31, 2025 | 1.86 Mn |
| Dec 31, 2025 | 1.86 Mn |
| Sep 30, 2025 | 9.80 Mn |
| Sep 30, 2025 | 9.80 Mn |
| Jun 30, 2025 | 5.64 Mn |
| Jun 30, 2025 | 5.64 Mn |
| Mar 31, 2025 | 5.80 Mn |
| Mar 31, 2025 | 5.80 Mn |
| Dec 31, 2024 | 1.81 Mn |
| Dec 31, 2024 | 1.81 Mn |
| Sep 30, 2024 | 21.55 Mn |
| Sep 30, 2024 | 21.55 Mn |
| Jun 30, 2024 | 12.87 Mn |
| Jun 30, 2024 | 12.87 Mn |
| Mar 31, 2024 | 55.37 Mn |
| Mar 31, 2024 | 55.37 Mn |
| Dec 31, 2023 | 164,000.00 |
| Dec 31, 2023 | 164,000.00 |